Related by context. Frequent words. (Click for all words.) 68 pseudobulbar affect PBA 65 sodium Injection 62 KNS # 62 Genasense R oblimersen 61 transcriptase inhibitor NNRTI 61 investigational drug 61 intravenous formulation 61 injectable formulation 60 Icatibant 60 alvimopan 60 diabetic neuropathic pain 60 Gabapentin GR 60 humanized monoclonal antibody 59 tezampanel 59 CXA 59 Phase IIb clinical 59 Phase 2a clinical 59 Riquent 59 Zerenex 59 Phase 2b clinical 59 Nexavar ® 59 6R BH4 59 MAP# 59 HCV protease inhibitor 59 NKTR 58 investigational oral 58 Phase 2a trial 58 SCH # 58 opioid induced constipation 58 phase IIa 58 orally bioavailable 58 Phase III clinical 58 relapsed refractory multiple myeloma 57 MBP# [001] 57 Pivotal Phase III 57 zileuton 57 Stedivaze 57 ELND# 57 confirmatory Phase III 57 Zelrix 57 Laquinimod 57 active comparator 57 Pirfenidone 57 Elesclomol 56 confirmatory Phase 3 56 VQD 56 Rhucin ® 56 Asentar 56 BEMA Buprenorphine 56 investigational compound 56 ICA # 56 orally administered 56 mixed dyslipidemia 56 LEVADEX 56 Phase III clinical trials 56 phase IIb 56 SILENOR TM 56 rNAPc2 56 Pivotal Phase 56 Amrubicin 56 Phase 1b clinical 56 intravenously administered 56 relapsed multiple myeloma 56 Phase 2b study 56 Phase IIa clinical 56 non alcoholic steatohepatitis 56 refractory Hodgkin lymphoma 55 HGS ETR1 55 Brentuximab vedotin 55 humanized anti 55 Synavive 55 CRx 55 tanespimycin 55 BAY #-# 55 Azedra 55 ADX# 55 PRX # 55 thymalfasin 55 dimebon 55 RGB # 55 ecallantide 55 Phase IIa 55 prGCD 55 Phenoptin 55 DAVANAT R 55 LY# [002] 55 DAVANAT 55 Anturol 55 CORLUX 55 Phase 1b trial 54 MOR# 54 regadenoson 54 pivotal Phase III 54 Voreloxin 54 LymphoStat B 54 Biolex Therapeutics 54 relapsing remitting multiple sclerosis 54 cangrelor 54 PEG Interferon lambda 54 ocrelizumab 54 NGX#